標(biāo)題: Titlebook: Urological Cancers in Clinical Practice; Jonathan Waxman (Professor of Oncology) Book 2007 Springer-Verlag London 2007 Urological Cancers. [打印本頁] 作者: sulfonylureas 時(shí)間: 2025-3-21 18:24
書目名稱Urological Cancers in Clinical Practice影響因子(影響力)
書目名稱Urological Cancers in Clinical Practice影響因子(影響力)學(xué)科排名
書目名稱Urological Cancers in Clinical Practice網(wǎng)絡(luò)公開度
書目名稱Urological Cancers in Clinical Practice網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Urological Cancers in Clinical Practice被引頻次
書目名稱Urological Cancers in Clinical Practice被引頻次學(xué)科排名
書目名稱Urological Cancers in Clinical Practice年度引用
書目名稱Urological Cancers in Clinical Practice年度引用學(xué)科排名
書目名稱Urological Cancers in Clinical Practice讀者反饋
書目名稱Urological Cancers in Clinical Practice讀者反饋學(xué)科排名
作者: 去世 時(shí)間: 2025-3-21 23:57 作者: PLE 時(shí)間: 2025-3-22 03:21 作者: 激怒某人 時(shí)間: 2025-3-22 05:15
Simon Chowdhury MB BS,Martin Gore MB BS, PhD, FRCP,Timothy G. Eisen PhD, FRCPinterviewsDit boek geeft iedereen die met ouders of kinderen omgaat, inzicht in de theorie over en praktijk van de preventie van kindermishandeling. Het boek is geschikt voor behandelaars, wijkteams, beleidsmakers, leerkrachten, verloskundigen, CJG-medewerkers, kraamverzorgenden en omstanders. Zij h作者: 信徒 時(shí)間: 2025-3-22 11:19 作者: upstart 時(shí)間: 2025-3-22 16:45
Thomas R. Geldart MB, BS, BSc, MRCP,Graham M. Mead DM, FRCP, FRCRtext that illuminates the statistics.Includes reflection and.This book addresses the development of our understanding of the abuse and neglect in the lives of children with disabilities. Disabilities in childhood uniquely dispose children for their abuse and neglect. Additionally, abuse and neglect 作者: 配置 時(shí)間: 2025-3-22 20:32
Gillian L. Smith MD, FRCS,Timothy J. Christmas MD, FRCS(Urol) towards later reproductive ages during the last four decades and review its consequences for children and their mothers in low-fertility countries in Europe, North America, Oceania and East Asia. First we analyse the trends in birth rates at advanced reproductive ages (35+) and document the rapid r作者: Antimicrobial 時(shí)間: 2025-3-22 21:51 作者: 使隔離 時(shí)間: 2025-3-23 04:27
Hormone Therapy for Prostate Cancer,Prostate cancer is now the most prevalent of all male malignancies and the second most common cause of male cancer deaths. Death rates have trebled over the last 30 years, and changes in mortality during this period are shown in Table 3.1 [.].作者: harangue 時(shí)間: 2025-3-23 09:00
Jonathan Waxman (Professor of Oncology)Encompasses all areas of urological cancers.Combines clinical and molecular advances in one volume.Appeals equally to urologists and oncologists.The well-known author has published over 250 research p作者: 羊欄 時(shí)間: 2025-3-23 10:51 作者: Water-Brash 時(shí)間: 2025-3-23 17:38
https://doi.org/10.1007/978-1-84628-507-3Urological Cancers; angiogenesis; cancer; cell; chemotherapy; hormone therapy; hormones; oncology; prostate 作者: 桶去微染 時(shí)間: 2025-3-23 19:44 作者: 爭(zhēng)議的蘋果 時(shí)間: 2025-3-23 23:37 作者: ensemble 時(shí)間: 2025-3-24 03:22
Radical Radiotherapy for Prostate Cancer,(PSA) screening. Prostate-specific antigen testing has led specifically to an increase in the proportion of patients diagnosed with early-stage (localized) prostate cancer. Radical radiotherapy is one of the curative treatment options for localized prostate cancer and it also has a role to play in l作者: 和音 時(shí)間: 2025-3-24 06:41 作者: 圓桶 時(shí)間: 2025-3-24 14:08 作者: 過剩 時(shí)間: 2025-3-24 16:06
Treatment Options in Superficial (pTa/pT1/CIS) Bladder Cancer,he United Kingdom, 13,600 new cases per annum contribute 5% to the national cancer burden [.]. Over 100,000 diagnostic, check, and interventional cystoscopies each year are performed in surveillance protocols in attempting to monitor for disease progression. In the United States, there were approxim作者: 付出 時(shí)間: 2025-3-24 19:18 作者: 無價(jià)值 時(shí)間: 2025-3-25 01:05 作者: LINE 時(shí)間: 2025-3-25 05:28 作者: 確定 時(shí)間: 2025-3-25 07:29
Chemotherapy for Testicular Cancer,ntaining chemotherapy in the mid-1970s, chemotherapy was highly toxic, and gave poor results, with cure unusual in those with advanced disease. Following the introduction of cisplatin, and subsequently etoposide, progress has been rapid, not least in the development of ancillary drugs (e.g., 5- hydr作者: 大喘氣 時(shí)間: 2025-3-25 15:38 作者: 多嘴多舌 時(shí)間: 2025-3-25 17:48 作者: 序曲 時(shí)間: 2025-3-25 21:53
Book 2007 and scientific interest, where advances in clinical practice and translational research have led to significant changes in the way that patients are managed....The book summarizes developments in all areas of urological cancer. The aim of the book is to educate urologists and oncologists so that th作者: 眨眼 時(shí)間: 2025-3-26 03:13
Radical Radiotherapy for Prostate Cancer,ocally advanced and even metastatic disease. This chapter reviews the relative merits of radiotherapy in comparison to the other management options for early prostate cancer and summarizes the staggering technological advances that have occurred in prostate radiotherapy over the last decade.作者: 招致 時(shí)間: 2025-3-26 07:55
Chemotherapy in Prostate Cancer,as been shown to have palliative benefit in symptomatic HRPC, but has not yet been demonstrated to prolong survival. Median life expectancy for patients with HRPC is only 12 to 18 months, underscoring the urgent need for new therapeutic approaches [.].作者: 案發(fā)地點(diǎn) 時(shí)間: 2025-3-26 10:54
Chemotherapy for Testicular Cancer,oxytryptamine [5-HT.] antagonists and growth factors). Modern therapy is now usually curative, tolerable, and has few long-term side effects. Indeed, the current dearth of randomized trials for most subgroups of these patients is largely a testimony to the advances taking place during this period.作者: Monolithic 時(shí)間: 2025-3-26 15:05
The Clinical Management of Penile Cancer,0,000 men in the cities of Sao Paulo and Recife, respectively [.]. Within Africa, the highest incidence has been reported from Uganda, where it is the most common cancer in males [.]. In India the disease is more common in the rural population with an incidence of 3 per 100,000 people accounting for more than 6% of all cancers in rural men [.].作者: CUMB 時(shí)間: 2025-3-26 16:49
Book 2007ey are able to understand scientific developments within urological oncology and be up to date with clinical practice in this area. The book provides a guide for clinical practice....This practical handbook provides a distillation of current practice for oncologists and urologists in clinical practice..作者: Blasphemy 時(shí)間: 2025-3-27 00:13 作者: 說笑 時(shí)間: 2025-3-27 04:03
Cytokine and Angiogenesis Inhibitors,of patients with localized disease can be cured by nephrectomy; however, at presentation approximately 50% of patients have locally advanced or metastatic disease [.]. The outlook for these patients remains poor, with a 5-year survival of less than 10% [.].作者: 業(yè)余愛好者 時(shí)間: 2025-3-27 08:27 作者: 刻苦讀書 時(shí)間: 2025-3-27 09:53 作者: 木質(zhì) 時(shí)間: 2025-3-27 16:16
Mererid Evans MB BCh, BSc, PhD, MRCP,Malcolm D. Mason MD, FRCP, FRCR作者: 使激動(dòng) 時(shí)間: 2025-3-27 21:48
Mark R. Feneley MD, FRCS,Roger S. Kirby MA, MD, FRCS作者: 運(yùn)動(dòng)的我 時(shí)間: 2025-3-28 00:37
Gairin J. Dancey MRCP,Jonathan Waxman BSc, MD, FRCPPraktischer Teil作者: 子女 時(shí)間: 2025-3-28 03:45 作者: 擦掉 時(shí)間: 2025-3-28 06:56
date with clinical practice in this area. The book provides a guide for clinical practice....This practical handbook provides a distillation of current practice for oncologists and urologists in clinical practice..978-1-84628-464-9978-1-84628-507-3作者: RLS898 時(shí)間: 2025-3-28 12:07 作者: 撕裂皮肉 時(shí)間: 2025-3-28 15:13
Simon Chowdhury MB BS,Martin Gore MB BS, PhD, FRCP,Timothy G. Eisen PhD, FRCP zich voornamelijk bezig het met het voorkomen van geestelijke gezondheidsklachtenen komt op voor kinderen in nood. Van Gameren werkt bij Stichting Kinderbelang en Transparant Training. Ze is auteur van.Leven met een psychisch zieke ouder., dat eerder verscheen bij BSL..978-90-368-1875-9978-90-368-1876-6作者: Organonitrile 時(shí)間: 2025-3-28 22:15 作者: 增減字母法 時(shí)間: 2025-3-29 01:16 作者: 裝勇敢地做 時(shí)間: 2025-3-29 05:22 作者: homocysteine 時(shí)間: 2025-3-29 10:27
Thomas R. Geldart MB, BS, BSc, MRCP,Graham M. Mead DM, FRCP, FRCRlldevelop a new understanding of their roles in universal, secondary, and tertiary level prevention that is targeted, focused, data-based, and designed to prevent the abuse and neglect of children with disabili978-3-319-80811-6978-3-319-30442-7作者: 沉著 時(shí)間: 2025-3-29 12:08 作者: 流出 時(shí)間: 2025-3-29 16:33
Treatment Options in Superficial (pTa/pT1/CIS) Bladder Cancer,ed with a variety of clinical scenarios. This chapter provides an overview of the current rationale behind the therapeutic options available for superficial bladder cancer treatment. In this way, it is hoped to empower clinicians with a broad sweep of the evidence on which therapy is based.
